Government Decisions on Access to Medicines: How Patient Voices can Make a Difference

Printer-friendly versionPrinter-friendly version

In reviewing new medical treatments for drugs, Canadian public drug programs and national agencies encourage stakeholders to provide written submissions on the impacts of diseases, current therapies and expectations for a new treatment. Thus the focus of these workshops will be to help patients, caregivers and other health system stakeholders to understand the process for making a written submission, including who is eligible to submit input, what the agencies and review committees are looking for, and how to make an effective case for coverage.

This is a half-day “live” workshop designed to help you and your organization learn about how to develop impactful patient health technology assessment submissions and government engagement strategies.

This Advocacy School workshop has been made possible with the support of Otsuka Canada Pharmaceutical Ltd. and Lundbeck Canada Inc., companies that are focused on important unmet medical needs, especially in the area of mental health.

This session will be offered live in a half-day workshop.

This event is a first-come, first served workshop - while we hope to be able to accommodate everybody, we may need to limit numbers to ensure participation by everybody.  If there is sufficient interest and we are unable to accommodate your participation this time, we will be looking to arrange a future workshop and will provide other opportunities to take part, such as a webinar.